International Flavors & FragrancesIFF
IFF
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
211% more call options, than puts
Call options by funds: $212M | Put options by funds: $68.3M
3.78% more ownership
Funds ownership: 89.17% [Q3] → 92.95% (+3.78%) [Q4]
4% less funds holding
Funds holding: 776 [Q3] → 747 (-29) [Q4]
15% less first-time investments, than exits
New positions opened: 94 | Existing positions closed: 110
16% less capital invested
Capital invested by funds: $23.9B [Q3] → $20.1B (-$3.83B) [Q4]
29% less repeat investments, than reductions
Existing positions increased: 224 | Existing positions reduced: 315
38% less funds holding in top 10
Funds holding in top 10: 16 [Q3] → 10 (-6) [Q4]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$82
5%
upside
Avg. target
$100
28%
upside
High target
$105
34%
upside
6 analyst ratings
5 positive
83%
1 neutral
17%
0 negative
0%
Barclays Lauren Lieberman 44% 1-year accuracy 43 / 97 met price target | 5%upside $82 | Equal-Weight Maintained | 27 Mar 2025 |
Oppenheimer Kristen Owen 32% 1-year accuracy 13 / 41 met price target | 33%upside $104 | Outperform Maintained | 20 Feb 2025 |
JP Morgan Jeffrey Zekauskas 28% 1-year accuracy 13 / 46 met price target | 33%upside $104 | Overweight Maintained | 20 Feb 2025 |
B of A Securities Matthew DeYoe 0% 1-year accuracy 0 / 3 met price target | 29%upside $101 | Buy Maintained | 20 Feb 2025 |
Wells Fargo Michael Sison 2% 1-year accuracy 1 / 44 met price target | 34%upside $105 | Overweight Maintained | 20 Feb 2025 |
Financial journalist opinion
Based on 5 articles about IFF published over the past 30 days
Neutral
Business Wire
21 hours ago
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio's production wi.

Neutral
Business Wire
3 days ago
IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025
TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral disintegrating tablets (ODTs), controlled-release formulations, and novel complex formulations at booth 5K-21, Tokyo Big Sight East Halls 4-6, April 9-11. “IFF Pharma Solutions is committed to redefining drug delivery through material science innovation,” said Frank Zhao, commercial leader, IFF Phar.

Neutral
Zacks Investment Research
3 days ago
International Flavors Stock Dips 24% in 6 Months: Will It Bounce Back?
IFF is likely to gain from demand for flavors & fragrances amid high costs and lower Food Ingredients business volumes.

Negative
Zacks Investment Research
1 week ago
Why Is International Flavors (IFF) Down 1.8% Since Last Earnings Report?
International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?

Neutral
Business Wire
3 weeks ago
IFF Declares Dividend for First Quarter 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 2025 to shareholders of record as of March 21, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—ad.

Neutral
Business Wire
1 month ago
IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today unveiled plans to expand its Cedar Rapids, Iowa facility to capture a larger share of the booming healthy snacks market both in the U.S. and globally. The 47,000-square-foot expansion represents a nearly $70 million investment. When fully operational in the latter half of 2026, the expansion is projected to create up to 40 new jobs. “Our Cedar Rapids plant will be equipped with cutting-edge technologies, allowing us to provide U.S.-made TAURA by.

Neutral
Business Wire
1 month ago
IFF Announces Executive Leadership Team Aligned With New Operating Model
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company's external reporting structure. After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM's president of precision fermentation and ADM Ventures, will join IFF as president of Health and Biosciences. “Since 2019, Simon has driven growth and operational effectiveness through innovat.

Neutral
Seeking Alpha
1 month ago
International Flavors & Fragrances Inc. (IFF) Q4 2024 Earnings Call Transcript
International Flavors & Fragrances Inc. (NYSE:IFF ) Q4 2024 Earnings Call Transcript February 19, 2025 9:00 AM ET Company Participants Michael Bender - Director, Investor Relations Erik Fyrwald - Chief Executive Officer Michael DeVeau - EVP, Chief Financial Officer Conference Call Participants Kristen Owen - Oppenheimer Josh Spector - UBS Nicola Tang - BNP Paribas Emily Fusco - Deutsche Bank Eric Zhang - Citi Lisa Neve - Morgan Stanley Steve Byrne - Bank of America John Roberts - Mizuho Mike Sison - Wells Fargo Matt Hettwer - Vertical Research Partners Mark Astrachan - Stifel Kate Grafstein - Barclays Silke Kueck - JPMorgan Dan Rizzo - Jefferies Artem Chubarov - Redburn Atlantic Harris Fein - Wolfe Research Operator Good morning. At this time, I would like to welcome everyone to the IFF's Fourth Quarter and Full Year 2024 Earnings Conference Call.

Positive
Zacks Investment Research
1 month ago
International Flavors Q4 Earnings Beat Estimates, Sales Rise Y/Y
IFF Q4 results reflect the impacts of growth across all segments and productivity gains.

Positive
Zacks Investment Research
1 month ago
International Flavors (IFF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for International Flavors (IFF) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Charts implemented using Lightweight Charts™